Drug class
Oxytocin-receptor antagonist; tocolytic peptide
Mechanism of action
Competitively antagonises oxytocin at its receptor and also binds vasopressin receptors; this reduces uterine contraction frequency and tone.
General use cases
- Delay of imminent pre-term birth in selected pregnant adult women meeting the product-specific clinical criteria
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
